BioMarin Pharma News, BioMarin Pharma Quote, BMRN Quote

BioMarin Pharma (NQ:BMRN) Delayed: 66.99 +0.35 (0.53%)

Prev. Close

$66.64

Today 6M 1Y 5Y

Open

$67.21

52 Wk High

$108.96

52 Wk Low

$62.12

Day High

$68.27

Day Low

$66.84

P/E

N/A

EPS

$-1.27

Volume

1,942,499

Friends, Peers and Foes (?): ALNY, REGN, IONS, VRTX, FOLD (more...)

ALERTS | RSS

Aug 18, 2026 04:13 PM BMO Capital Starts BioMarin Pharmaceutical Inc. (BMRN) at Outperform
Aug 18, 2026 08:39 AM Form 8-K BIOMARIN PHARMACEUTICAL For: Aug 17
Aug 18, 2026 08:31 AM BioMarin to acquire Alesta Therapeutics for $275M upfront
Aug 18, 2026 08:30 AM BioMarin to Acquire Alesta Therapeutics to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia, Adding an Important Clinical Program to BioMarin's Pipeline
Aug 17, 2026 07:43 AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $88 at Piper Sandler
Aug 17, 2026 04:51 AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $111 at Barclays
Aug 10, 2026 09:05 AM BioMarin to Participate at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM ET in Boston
Aug 10, 2026 07:00 AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $114 at Canaccord
Aug 7, 2026 10:22 AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $70 at Stifel
Aug 7, 2026 06:17 AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $97 at Oppenheimer

Entities mentioned with BMRN

View All Entities